Patents by Inventor Shibo Jiang

Shibo Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210019019
    Abstract: Some embodiments of the present disclosure provide a signal processing system, a chip and an active stylus. The signal processing system includes: a pre-amplifier circuit, configured to pre-amplify a received DSSS signal and output a pre-amplified DSSS signal; a low-pass filter circuit, configured to filter the pre-amplified DSSS signal and output a filtered DSSS signal; an analog-to-digital converter circuit, configured to sample the filtered DSSS signal and output a sampled DSSS signal; a noise detecting and filtering-out circuit, configured to filter out a noise in the sampled DSSS signal and output a noise-filtered DSSS signal; and a digital demodulation circuit, configured to demodulate the noise-filtered DSSS signal to output a demodulated signal. The signal processing system can have strong anti-interference ability and high sensitivity through the noise detecting and filtering-out circuit and automatically controlling a gain of the pre-amplifier circuit.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 21, 2021
    Inventors: Guanjun ZHANG, Shibo LI, Feipeng JIANG
  • Publication number: 20190328865
    Abstract: Described herein are immunogenic compositions for preventing infection with Middle East respiratory syndrome coronavirus (MERS-CoV) wherein the immunogenic compositions comprise at least a portion of the MERS-CoV S protein and an immunopotentiator.
    Type: Application
    Filed: November 17, 2017
    Publication date: October 31, 2019
    Inventors: Lanying Du, Fang Li, Shibo Jiang, Yusen Zhou
  • Patent number: 10424756
    Abstract: The present application provides a flexible display apparatus and a white light organic electroluminescent device including an anode, a first blue light emitting unit, a second yellow light emitting unit, a third blue light emitting unit, and a cathode successively laminated and disposed, wherein the second yellow light emitting unit including a red light emitting layer. The flexible display apparatus and a white light organic electroluminescent device provided by the application enhances the luminous intensity of the red light band in the three-laminated layer white light organic electroluminescent device by adding a red light emitting layer, and optimizes the spectrum of the white OLED device, when used as a display device it can reduce power consumption of the display apparatus.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: September 24, 2019
    Assignee: Shenzhen China Star Optoelectronics Technology Co., Ltd
    Inventors: Aiguo Tu, Jinchuan Li, Liang Jiang, Wei Yuan, Yang Liu, Shibo Jiao
  • Patent number: 9943589
    Abstract: Disclosed herein are immunogenic compositions for preventing infection with influenza viruses wherein the immunogenic compositions comprises an immunogen such as a hemagglutinin of an influenza virus, and an immunopotentiator such as an Fc fragment of human IgG and optionally a stabilization sequence. The immunogen is linked to the stabilization sequence which in turn is linked to the immunopotentiator.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: April 17, 2018
    Assignee: NEW YORK BLOOD CENTER, INC.
    Inventors: Shibo Jiang, Lanying Du
  • Patent number: 9889194
    Abstract: Described herein are immunogenic compositions for preventing infection with Middle East respiratory syndrome coronavirus (MERS-CoV) wherein the immunogenic compositions comprise at least a portion of the MERS-CoV S protein and an immunopotentiator.
    Type: Grant
    Filed: February 28, 2014
    Date of Patent: February 13, 2018
    Assignee: New York Blood Center, Inc.
    Inventors: Shibo Jiang, Lanying Du, Yusen Zhou, Guangyu Zhao
  • Patent number: 9724383
    Abstract: Disclosed herein are trimeric polypeptide pharmaceutical compositions comprising three monomers, each monomer comprising a polypeptide having the amino acid sequence of the N-terminal heptad repeat (NHR or HR1) or C-terminal heptad repeat (CHR or HR2) of the transmembrane glycoprotein of human immunodeficiency virus (HIV) and a trimerization motif.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: August 8, 2017
    Assignee: New York Blood Center, Inc.
    Inventors: Shibo Jiang, Zhi Qi, Xi Chen, Chungen Pan
  • Patent number: 9701736
    Abstract: Disclosed herein are neutralizing antibodies with cross-neutralizing activity and cross-protective effects against divergent stains of influenza virus, which are specific for an epitope having at least 90% homology to amino acids +72-115 of the HA1 domain of H5N1 influenza virus hemagglutinin.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: July 11, 2017
    Assignee: New York Blood Center, Inc.
    Inventors: Shibo Jiang, Lanying Du, Yusen Zhou
  • Publication number: 20170182148
    Abstract: Disclosed herein are immunogenic compositions for preventing infection with influenza viruses wherein the immunogenic compositions comprises an immunogen such as a hemagglutinin of an influenza virus, and an immunopotentiator such as an Fc fragment of human IgG and optionally a stabilization sequence. The immunogen is linked to the stabilization sequence which in turn is linked to the immunopotentiator.
    Type: Application
    Filed: January 26, 2017
    Publication date: June 29, 2017
    Inventors: Shibo Jiang, Lanying Du
  • Patent number: 9592287
    Abstract: Disclosed herein are immunogenic compositions for preventing infection with influenza viruses wherein the immunogenic compositions comprises an immunogen such as a hemagglutinin of an influenza virus, and an immunopotentiator such as an Fc fragment of human IgG and optionally a stabilization sequence. The immunogen is linked to the stabilization sequence which in turn is linked to the immunopotentiator.
    Type: Grant
    Filed: October 5, 2010
    Date of Patent: March 14, 2017
    Assignee: New York Blood Center, Inc.
    Inventors: Shibo Jiang, Lanying Du
  • Publication number: 20160296617
    Abstract: Described herein are immunogenic compositions for preventing infection with Middle East respiratory syndrome coronavirus (MERS-CoV) wherein the immunogenic compositions comprise at least a portion of the MERS-CoV S protein and an immunopotentiator.
    Type: Application
    Filed: February 28, 2014
    Publication date: October 13, 2016
    Inventors: Shibo Jiang, Lanying Du, Yusen Zhou, Guangyu Zhao
  • Publication number: 20160000900
    Abstract: Embodiments are provided for network resource allocation considering user experience, satisfaction, and operator interest. An embodiment method by a network component for allocating network resources includes evaluating, for a user, a QoE for each flow of a plurality of flows in network traffic in according with a QoE model, and further evaluating, for an operator, a revenue associated with the flows in accordance with a revenue model. A plurality of priorities that correspond to the flows are calculated in accordance with the QoE for the user and the revenue for the operator. The method further includes identifying a flow of the flows with a highest value of the priorities, and allocating a network resource for the flow. In an embodiment, the QoE model is a satisfaction model that provides a measure of user satisfaction for each flow in accordance with a subscription or behavior class of the user.
    Type: Application
    Filed: February 14, 2014
    Publication date: January 7, 2016
    Inventors: Yusen Zhou, Guangyu Zhao, Shibo Jiang, Lanying Du
  • Publication number: 20150306174
    Abstract: Disclosed herein are trimeric polypeptide pharmaceutical compositions comprising three monomers, each monomer comprising a polypeptide having the amino acid sequence of the N-terminal heptad repeat (NHR or HR1) or C-terminal heptad repeat (CHR or HR2) of the transmembrane glycoprotein of human immunodeficiency virus (HIV) and a trimerization motif.
    Type: Application
    Filed: July 10, 2015
    Publication date: October 29, 2015
    Inventors: Shibo Jiang, Zhi Qi, Xi Chen, Chungen Pan
  • Patent number: 9115186
    Abstract: Disclosed herein are trimeric polypeptide pharmaceutical compositions comprising three monomers, each monomer comprising a polypeptide having the amino acid sequence of the N-terminal heptad repeat (NHR or HR1) or C-terminal heptad repeat (CHR or HR2) of the transmembrane glycoprotein of human immunodeficiency virus (HIV) and a trimerization motif.
    Type: Grant
    Filed: February 8, 2010
    Date of Patent: August 25, 2015
    Assignee: New York Blood Center
    Inventors: Shibo Jiang, Zhi Qi, Xi Chen, Chungen Pan
  • Publication number: 20150030607
    Abstract: Disclosed herein are neutralizing antibodies with cross-neutralizing activity and cross-protective effects against divergent stains of influenza virus, which are specific for an epitope having at least 90% homology to amino acids +72-115 of the HA1 domain of H5N1 influenza virus hemagglutinin.
    Type: Application
    Filed: October 9, 2014
    Publication date: January 29, 2015
    Inventors: Shibo Jiang, Lanying DU, Yusen Zhou
  • Patent number: 8936789
    Abstract: Provided herein are immunogenic compositions comprising fusion proteins, the fusion proteins comprising lentivirus gp41 or a fragment thereof, a trimerization or oligomerization motif and an immunoenhancer that elicit potent and broad HIV neutralizing antibody responses in the immunized hosts. Also disclosed are methods of making and using the immunogenic compositions.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: January 20, 2015
    Assignee: New York Bood Center, Inc.
    Inventors: Shibo Jiang, Zhi Qi, Chungen Pan
  • Patent number: 8933106
    Abstract: The invention relates to 2-(4-Substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside HIV reverse transcriptase, preparation methods and uses thereof. Specifically, the invention relates to compounds of formula I or the pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7 and X are as defined in the description. The compounds of formula I of the invention are a type of anti-HIV active compounds having new backbone structure.
    Type: Grant
    Filed: September 28, 2009
    Date of Patent: January 13, 2015
    Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Lan Xie, Xingtao Tian, Kuo-Hsiung Lee, Shibo Jiang, Hong Lu
  • Patent number: 8900585
    Abstract: Disclosed herein are neutralizing antibodies with cross-neutralizing activity and cross-protective effects against divergent stains of influenza virus, which are specific for an epitope having at least 90% homology to amino acids +72-115 of the HA1 domain of H5N1 influenza virus hemagglutinin.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: December 2, 2014
    Assignee: New York Blood Center, Inc.
    Inventors: Shibo Jiang, Lanying Du, Yusen Zhou
  • Patent number: 8828932
    Abstract: Disclosed herein are bifunctional molecules which inactivate human immunodeficiency virus (HIV) even before the virus attacks the target cell and inhibits HIV entry into the target cell. Also disclosed are novel anti-HIV therapeutics for treatment of patients infected by HIV. Further disclosed are methods for prophylaxis against HIV and treatment of HIV infection.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: September 9, 2014
    Assignee: New York Blood Center, Inc.
    Inventors: Shibo Jiang, Chungen Pan, Lu Lu
  • Patent number: 8828931
    Abstract: Disclosed herein are bifunctional molecules which inhibit HIV entry into the target cell. Also disclosed are novel anti-HIV therapeutics for treatment of patients infected by HIV, including non-B and multi-drug resistant strains.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: September 9, 2014
    Assignee: New York Blood Center, Inc.
    Inventors: Shibo Jiang, Chungen Pan
  • Patent number: 8744824
    Abstract: An optimizing design method for a chassis structure of electronic equipment is disclosed, including: investigating from the point of view of mechanical, electric and thermal three-field coupling, determining the preliminary design size of the chassis, performing a mechanical analysis by using a mechanical analysis software such as ANSYS; converting the mesh model among the three-fields, obtaining the mesh model used for the electromagnetic and thermal analyses; setting the thermal analysis parameters, performing the thermal analysis by using an electromagnetic analysis software such as ICEPAK; determining a resonance frequency of the chassis and an electric parameter of the absorbing material, performing an electromagnetic analysis by using a thermal analysis software such as FEKO; correcting the analysis result by sample testing; determining whether the chassis satisfies the design requirement, if it satisfies the requirement, the optimizing design will be finished, otherwise, modifying the preliminary compu
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: June 3, 2014
    Assignee: Xidian University
    Inventors: Baoyan Duan, Hui Qiao, Peng Li, Shibo Jiang, Boyuan Ma, Ning Han, Lizhi Zeng, Yu He